| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $949K | -11.8% |
| R&D Expense | $516K | -42.7% |
| SG&A Expense | $224K | -25.4% |
| Operating Income | $127K | +137.0% |
| Interest Expense | $185K | +21.4% |
| Net Income | -$59K | -135.3% |
| EPS (Basic) | $0.00 | — |
| EPS (Diluted) | $0.00 | — |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6K | +648.1% |
| Accounts Receivable | $132K | -64.6% |
| Current Assets | $140K | -62.9% |
| Total Assets | $3.8M | -7.0% |
| Current Liabilities | $1.7M | -15.8% |
| Long-term Debt | $25K | +6.2% |
| Total Liabilities | $3.6M | -3.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23K | -108.3% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | $28K | +110.3% |
| Stockholders' Equity |
| $156K |
| -47.8% |